摘要
呫吨酮类衍生物是一类具有多种药理活性专用支架的化合物,这使得人们有兴趣将它发展成为备选药物。然而,为了达到这个目的,关键是要研究它们的药物代谢动力学和毒性(PK/tox),这是决定它们被继续研究或被中断研究的决策点。这篇综述旨在揭示在生物化学和PK/tox研究中最相关的研究方法,来发现、定量和确认不同的生物活性呫吨酮。对(此类化合物)体内外系统中吸收、分布、代谢和排泄特性(如:溶解度、亲脂性、酸碱度、化学和代谢稳定性、渗透性、转运蛋白调制和血浆蛋白结合)的主要结果进行分析,有希望揭示调整PK性质的一些威胁物,来了解呫吨酮类衍生物的生物利用度和药物可能性。此综述最后一节着重于候选药物DMXAA的发展这一案例研究,这一研究已到达临床试验(阶段),可以为这个支架提供途径和PK/tox参数。这篇综述中所收集的数据是为了引导有呫吨酮类支架的潜在先导化合物与候选药物的设计中问题的解决。
关键词: 药物发展,代谢,药物代谢动力学,生物化学性质,预临床,呫吨酮,毒性
Current Medicinal Chemistry
Title:Drug-like Properties and ADME of Xanthone Derivatives: The Antechamber of Clinical Trials
Volume: 23 Issue: 32
Author(s): Ana Sara Gomes, Pedro Brandão, Carla Sofia Garcia Fernandes, Marta Ramos Pinto Correia da Silva and Maria Emília da Silva Pereira de Sousa, Madalena Maria de Magalhães Pinto
Affiliation:
关键词: 药物发展,代谢,药物代谢动力学,生物化学性质,预临床,呫吨酮,毒性
摘要: Xanthone derivatives have been described as compounds with a privileged scaffold exhibiting diverse biological/pharmacological activities, what directed the interest to pursue the development of these derivatives into drug candidates. Nevertheless, to achieve this purpose it is crucial to study their pharmacokinetics and toxicity (PK/tox) properties as decision endpoints to continue or interrupt the development investment. This review aims to expose the most relevant analytical methods used in the physicochemical and PK/tox studies in order to detect, quantify, and identify different bioactive xanthones. Analyzing the main results from in vitro and in vivo systems towards ADME properties such as solubility, lipophilicity, pKa, chemical and metabolic stability, permeability, transporters modulation, and plasma protein binding, it is possible to uncover some threats governing the PK properties and to understand the bioavailability and drugability of xanthone derivatives. The last section of this review focuses on a case-study of the development of the drug candidate DMXAA, which has reached clinical trials, to provide the paths and the importance of PK/tox parameters of this scaffold. The data assembled in this review intends to guide for tackling issues in the design of potential lead compounds and drug candidates with a xanthone scaffold.
Export Options
About this article
Cite this article as:
Ana Sara Gomes, Pedro Brandão, Carla Sofia Garcia Fernandes, Marta Ramos Pinto Correia da Silva and Maria Emília da Silva Pereira de Sousa, Madalena Maria de Magalhães Pinto , Drug-like Properties and ADME of Xanthone Derivatives: The Antechamber of Clinical Trials, Current Medicinal Chemistry 2016; 23 (32) . https://dx.doi.org/10.2174/0929867323666160425113058
DOI https://dx.doi.org/10.2174/0929867323666160425113058 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements